Monday, January 7, 2008

Development of a Scalable Process for DG-041, a Potent EP3 Receptor Antagonist, via Tandem Heck Reactions



Org. Process Res. Dev., 11 (4), 747 -753
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)